Full Text:  <639>

Summary:  <150>

CLC number: 

On-line Access: 2024-08-27

Received: 2023-10-17

Revision Accepted: 2024-05-08

Crosschecked: 2024-10-18

Cited: 0

Clicked: 807

Citations:  Bibtex RefMan EndNote GB/T7714

 ORCID:

Yi WANG

https://orcid.org/0000-0002-1350-2961

Zhong CHEN

https://orcid.org/0000-0003-4755-9357

Di WU

https://orcid.org/0000-0002-2176-2691

-   Go to

Article info.
Open peer comments

Journal of Zhejiang University SCIENCE B

Accepted manuscript available online (unedited version)


Phenolic-enabled nanotechnology: a new strategy for central nervous system disease therapy


Author(s):  Yuyi ZHENG, Xiaojie CHEN, Yi WANG, Zhong CHEN, Di WU

Affiliation(s):  Key Laboratory of Neuropharmacology and Translational Medicine of Zhejiang Province, School of Pharmaceutical Sciences, Zhejiang Chinese Medical University,Hangzhou310053,China; more

Corresponding email(s):  wudichem@zju.edu.cn, wang-yi@zju.edu.cn, chenzhong@zju.edu.cn

Key Words:  Phenolic-enabled nanotechnology (PEN); Metal-phenolic network; Polydopamine; Central nervous system (CNS); Drug delivery system


Share this article to: More <<< Previous Paper|Next Paper >>>

Yuyi ZHENG, Xiaojie CHEN, Yi WANG, Zhong CHEN, Di WU. Phenolic-enabled nanotechnology: a new strategy for central nervous system disease therapy[J]. Journal of Zhejiang University Science B,in press.Frontiers of Information Technology & Electronic Engineering,in press.https://doi.org/10.1631/jzus.B2300839

@article{title="Phenolic-enabled nanotechnology: a new strategy for central nervous system disease therapy",
author="Yuyi ZHENG, Xiaojie CHEN, Yi WANG, Zhong CHEN, Di WU",
journal="Journal of Zhejiang University Science B",
year="in press",
publisher="Zhejiang University Press & Springer",
doi="https://doi.org/10.1631/jzus.B2300839"
}

%0 Journal Article
%T Phenolic-enabled nanotechnology: a new strategy for central nervous system disease therapy
%A Yuyi ZHENG
%A Xiaojie CHEN
%A Yi WANG
%A Zhong CHEN
%A Di WU
%J Journal of Zhejiang University SCIENCE B
%P 890-913
%@ 1673-1581
%D in press
%I Zhejiang University Press & Springer
doi="https://doi.org/10.1631/jzus.B2300839"

TY - JOUR
T1 - Phenolic-enabled nanotechnology: a new strategy for central nervous system disease therapy
A1 - Yuyi ZHENG
A1 - Xiaojie CHEN
A1 - Yi WANG
A1 - Zhong CHEN
A1 - Di WU
J0 - Journal of Zhejiang University Science B
SP - 890
EP - 913
%@ 1673-1581
Y1 - in press
PB - Zhejiang University Press & Springer
ER -
doi="https://doi.org/10.1631/jzus.B2300839"


Abstract: 
Polyphenolic compounds have received tremendous attention in biomedicine because of their good biocompatibility and unique physicochemical properties. In recent years, phenolic-enabled nanotechnology (PEN) has become a hotspot of research in the medical field, and many promising studies have been reported, especially in the application of central nervous system (CNS) diseases. Polyphenolic compounds have superior anti-inflammatory and antioxidant properties, and can easily cross the blood‒brain barrier, as well as protect the nervous system from metabolic damage and promote learning and cognitive functions. However, although great advances have been made in this field, a comprehensive review regarding PEN-based nanomaterials for CNS therapy is lacking. A systematic summary of the basic mechanisms and synthetic strategies of PEN-based nanomaterials is beneficial for meeting the demand for the further development of novel treatments for CNS diseases. This review systematically introduces the fundamental physicochemical properties of PEN-based nanomaterials and their applications in the treatment of CNS diseases. We first describe the different ways in which polyphenols interact with other substances to form high-quality products with controlled sizes, shapes, compositions, and surface chemistry and functions. The application of PEN-based nanomaterials in the treatment of CNS diseases is then described, which provides a reference for subsequent research on the treatment of CNS diseases.

酚类纳米技术:治疗中枢神经系统疾病的新策略

郑玉艺1,陈晓劼1,汪仪1,2,陈忠1,吴迪1
1浙江中医药大学药学院,浙江省神经药理学与转化研究重点实验室,中国杭州市,310053
2浙江中医药大学附属第三医院,中国杭州市,310009
摘要:酚类化合物因其良好的生物相容性和独特的理化性质,在生物医学领域受到极大关注。近年来,酚类纳米技术已成为医学领域的研究热点,特别是在中枢神经系统疾病的应用方面,已报道了许多具有广阔前景的研究成果。酚类化合物的优越性能包括抗炎、抗氧化、消炎、易透过血脑屏障,以及保护神经系统免受代谢损伤、促进学习和认知功能等。尽管这一领域已取得了巨大进展,但仍缺乏有关酚类纳米材料在中枢神经系统疾病治疗的全面综述。本文系统地总结了酚类纳米材料的基本理化性质和合成策略,以期满足进一步开发新型中枢神经系统疾病治疗方法的需求。本文首先介绍了酚类物质与其他物质的相互作用,它们可以通过不同的方式形成尺寸、形状、成分、表面化学性质和功能均可控的纳米材料。随后,本文对酚类纳米材料在中枢神经系统疾病治疗中的应用进行总结,以期为该领域后续的应用研究提供参考。

关键词组:酚类纳米技术;金属酚醛网络;聚多巴胺;中枢神经系统;递药系统

Darkslateblue:Affiliate; Royal Blue:Author; Turquoise:Article

Reference

[1]AbbottNJ,PatabendigeAAK,DolmanDEM,et al.,2010.Structure and function of the blood‒brain barrier.Neurobiol Dis,37(1):13-25.

[2]Abdal DayemA,ChoiHY,YangGM,et al.,2016.The anti-cancer effect of polyphenols against breast cancer and cancer stem cells: molecular mechanisms.Nutrients,8(9):581.

[3]AgostinisP,BergK,CengelKA,et al.,2011.Photodynamic therapy of cancer: an update.CA Cancer J Clin,61(4):250-281.

[4]AiXZ,MuJ,XingBG,2016.Recent advances of light-mediated theranostics.Theranostics,6(13):2439-2457.

[5]AmbekarRS,KandasubramanianB,2019.A polydopamine-based platform for anti-cancer drug delivery.Biomater Sci,7(5):1776-1793.

[6]AppidiT,PemmarajuDB,KhanRA,et al.,2020.Light-triggered selective ROS-dependent autophagy by bioactive nanoliposomes for efficient cancer theranostics.Nanoscale,12(3):2028-2039.

[7]ArnedosM,VicierC,LoiS,et al.,2015.Precision medicine for metastatic breast cancer‒limitations and solutions.Nat Rev Clin Oncol,12(12):693-704.

[8]AvasthiA,CaroC,Pozo-TorresE,et al.,2020.Magnetic nanoparticles as MRI contrast agents.Top Curr Chem,378(3):40.

[9]BattagliaL,PancianiPP,MuntoniE,et al.,2018.Lipid nanoparticles for intranasal administration: application to nose-to-brain delivery.Expert Opin Drug Deliv,15(4):369-378.

[10]BeghiE,GiussaniG,SanderJW,2015.The natural history and prognosis of epilepsy.Epileptic Disord,17(3):243-253.

[11]BertranF,2018.Epilepsy today.Rev Infirm,67(243):14-16(in French).

[12]Brglez MojzerE,Knez HrnčičM,ŠkergetM,et al.,2016.Polyphenols: extraction methods, antioxidative action, bioavailability and anticarcinogenic effects.Molecules,21(7):901.

[13]BrunoRM,GhiadoniL,2018.Polyphenols, antioxidants and the sympathetic nervous system.Curr Pharm Des,24(2):130-139.

[14]ChenY,LuY,LeeRJ,et al.,2020.Nano encapsulated curcumin: and its potential for biomedical applications.Int J Nanomedicine,15:3099-3120.

[15]ChengTJ,LiuJJ,RenJ,et al.,2016.Green tea catechin-based complex micelles combined with doxorubicin to overcome cardiotoxicity and multidrug resistance.Theranostics,6(9):1277-1292.

[16]ChengW,ZengXW,ChenHZ,et al.,2019.Versatile polydopamine platforms: synthesis and promising applications for surface modification and advanced nanomedicine.ACS Nano,13(8):8537-8565.

[17]CheynierV,Tomas-BarberanFA,YoshidaK,2015.Polyphenols: from plants to a variety of food and nonfood uses.J Agric Food Chem,63(35):7589-7594.

[18]ChoS,ParkW,KimDH,2017.Silica-coated metal chelating-melanin nanoparticles as a dual-modal contrast enhancement imaging and therapeutic agent.ACS Appl Mater Interfaces,9(1):101-111.

[19]ChungJE,TanSS,GaoSJ,et al.,2014.Self-assembled micellar nanocomplexes comprising green tea catechin derivatives and protein drugs for cancer therapy.Nat Nanotechnol,9(11):907-912.

[20]CiQQ,QinXF,LiuJH,et al.,2020.Mitochondria-targeted polydopamine nanoprobes for visualizing endogenous sulfur dioxide derivatives in a rat epilepsy model.Chem Commun,56(79):11823-11826.

[21]CuiJW,YanY,SuchGK,et al.,2012.Immobilization and intracellular delivery of an anticancer drug using mussel-inspired polydopamine capsules.Biomacromolecules,13(8):2225-2228.

[22]DagliaM,2012.Polyphenols as antimicrobial agents.Curr Opin Biotechnol,23(2):174-181.

[23]DaiYL,ChengSY,WangZL,et al.,2018a.Hypochlorous acid promoted platinum drug chemotherapy by myeloperoxidase-encapsulated therapeutic metal phenolic nanoparticles.ACS Nano,12(1):455-463.

[24]DaiYL,YangZ,ChengSY,et al.,2018b.Toxic reactive oxygen species enhanced synergistic combination therapy by self-assembled metal-phenolic network nanoparticles.Adv Mater,30(8):1704877.

[25]DaleyMJ,MurthyMS,PetersonEJ,2015.Bleeding risk with systemic thrombolytic therapy for pulmonary embolism: scope of the problem.Ther Adv Drug Saf,6(2):57-66.

[26]de Lima CherubimDJ,Buzanello MartinsCV,Oliveira FariñaL,et al.,2020.Polyphenols as natural antioxidants in cosmetics applications.J Cosmet Dermatol,19(1):33-37.

[27]DingXG,LiowCH,ZhangMX,et al.,2014.Surface plasmon resonance enhanced light absorption and photothermal therapy in the second near-infrared window.J Am Chem Soc,136(44):15684-15693.

[28]DuanJN,GaoSQ,TuS,et al.,2021.Pathophysiology and therapeutic potential of NADPH oxidases in ischemic stroke-induced oxidative stress.Oxid Med Cell Longev,2021:6631805.

[29]DuanRR,SunK,FangF,et al.,2022.An ischemia-homing bioengineered nano-scavenger for specifically alleviating multiple pathogeneses in ischemic stroke.J Nanobiotechnology,20:397.

[30]EjimaH,RichardsonJJ,CarusoF,2017.Metal-phenolic networks as a versatile platform to engineer nanomaterials and biointerfaces.Nano Today,12:136-148.

[31]FanJX,ZhengDW,MeiWW,et al.,2017.A metal-polyphenol network coated nanotheranostic system for metastatic tumor treatments.Small,13(48):1702714.

[32]GanjeifarB,MorshedSF,2021.Targeted drug delivery in brain tumors-nanochemistry applications and advances.Curr Top Med Chem,21(14):1202-1223.

[33]GaoCH,WangYL,SunJJ,et al.,2020.Neuronal mitochondria-targeted delivery of curcumin by biomimetic engineered nanosystems in Alzheimer’s disease mice.Acta Biomater,108:285-299.

[34]GaoYF,ChengYX,ChenJP,et al.,2022.NIR-assisted MgO-based polydopamine nanoparticles for targeted treatment of Parkinson’s disease through the blood‒brain barrier.Adv Healthc Mater,11(23):2201655.

[35]GaoZ,ZharovI,2014.Large pore mesoporous silica nanoparticles by templating with a nonsurfactant molecule, tannic acid.Chem Mater,26(6):2030-2037.

[36]GeR,LinM,LiX,et al.,2017.Cu2+-loaded polydopamine nanoparticles for magnetic resonance imaging-guided pH- and near-infrared-light-stimulated thermochemotherapy.ACS Appl Mater Interfaces,9(23):19706-19716.

[37]GoldenEB,LamPY,KardoshA,et al.,2009.Green tea polyphenols block the anticancer effects of bortezomib and other boronic acid-based proteasome inhibitors.Blood,113(23):5927-5937.

[38]GregoryJV,KadiyalaP,DohertyR,et al.,2020.Systemic brain tumor delivery of synthetic protein nanoparticles for glioblastoma therapy.Nat Commun,11:5687.

[39]GuoJL,PingY,EjimaH,et al.,2014.Engineering multifunctional capsules through the assembly of metal-phenolic networks.Angew Chem Int Ed,53(22):5546-5551.

[40]GuoJL,TardyBL,ChristoffersonAJ,et al.,2016.Modular assembly of superstructures from polyphenol-functionalized building blocks.Nat Nanotechnol,11(12):1105-1111.

[41]GuoXY,HongT,ZangJ,et al.,2022.Thrombus-specific/responsive biomimetic nanomedicine for spatiotemporal thrombolysis and alleviation of myocardial ischemia/reperfusion injury.J Nanobiotechnology,20:531.

[42]GuoYX,SunQ,WuFG,et al.,2021.Polyphenol-containing nanoparticles: synthesis, properties, and therapeutic delivery.Adv Mater,33(22):2007356.

[43]GuoZH,XieWS,LuJS,et al.,2021.Tannic acid-based metal phenolic networks for bio-applications: a review.J Mater Chem B,9(20):4098-4110.

[44]GuoZH,KhattakS,RaufMA,et al.,2023.Role of nanomedicine-based therapeutics in the treatment of CNS disorders.Molecules,28(3):1283.

[45]HabibS,SinghM,2022.Angiopep-2-modified nanoparticles for brain-directed delivery of therapeutics: a review.Polymers,14(4):712.

[46]HanYY,LinZX,ZhouJJ,et al.,2020.Polyphenol-mediated assembly of proteins for engineering functional materials.Angew Chem Int Ed,59(36):15618-15625.

[47]HanYY,LafleurRPM,ZhouJJ,et al.,2022.Role of molecular interactions in supramolecular polypeptide-polyphenol networks for engineering functional materials.J Am Chem Soc,144(27):12510-12519.

[48]HassaniA,AzarianMMS,IbrahimWN,et al.,2020.Preparation, characterization and therapeutic properties of gum arabic-stabilized gallic acid nanoparticles.Sci Rep,10:17808.

[49]HeGL,ZhouY,LiMF,et al.,2021.Bioinspired synthesis of ZnO@polydopamine/Au for label-free photoelectrochemical immunoassay of amyloid-β protein.Front Bioeng Biotechnol,9:777344.

[50]HongS,KimKY,WookHJ,et al.,2011.Attenuation of thein vivo toxicity of biomaterials by polydopamine surface modification.Nanomedicine,6(5):793-801.

[51]HuB,WangY,XieMH,et al.,2015.Polymer nanoparticles composed with gallic acid grafted chitosan and bioactive peptides combined antioxidant, anticancer activities and improved delivery property for labile polyphenols.J Funct Foods,15:593-603.

[52]HuH,LiuX,HongJ,et al.,2022.Mesoporous polydopamine-based multifunctional nanoparticles for enhanced cancer phototherapy.J Colloid Interface Sci,612:246-260.

[53]HuJG,ZhangX,WenZH,et al.,2016.Asn-Gly-Arg-modified polydopamine-coated nanoparticles for dual-targeting therapy of brain glioma in rats.Oncotarget,7(45):73681-73696.

[54]JakobekL,2015.Interactions of polyphenols with carbohydrates, lipids and proteins.Food Chem,175:556-567.

[55]JenjobR,PhakkeereeT,CrespyD,2020.Core-shell particles for drug-delivery, bioimaging, sensing, and tissue engineering.Biomater Sci,8(10):2756-2770.

[56]JingZ,LiMH,WangHY,et al.,2021.Gallic acid-gold nanoparticles enhance radiation-induced cell death of human glioma U251 cells.IUBMB Life,73(2):398-407.

[57]KalaniA,KamatPK,KalaniK,et al.,2015.Epigenetic impact of curcumin on stroke prevention.Metab Brain Dis,30(2):427-435.

[58]KalariaRN,AkinyemiR,IharaM,2016.Stroke injury, cognitive impairment and vascular dementia.Biochim Biophys Acta,1862(5):915-925.

[59]KamathT,AbdulraoufA,BurrisSJ,et al.,2022.Single-cell genomic profiling of human dopamine neurons identifies a population that selectively degenerates in Parkinson’s disease.Nat Neurosci,25(5):588-595.

[60]KanYJ,DannerEW,IsraelachviliJN,et al.,2014.Boronate complex formation with Dopa containing mussel adhesive protein retards pH-induced oxidation and enables adhesion to mica.PLoS ONE,9(10):e108869.

[61]KatilaN,DuwaR,BhurtelS,et al.,2022.Enhancement of blood‒brain barrier penetration and the neuroprotective effect of resveratrol.J Control Release,346:1-19.

[62]KellyPJ,MorrowJD,NingMM,et al.,2008.Oxidative stress and matrix metalloproteinase-9 in acute ischemic stroke: the biomarker evaluation for antioxidant therapies in stroke (beat-stroke) study.Stroke,39(1):100-104.

[63]KevilCG,OshimaT,AlexanderB,et al.,2000.H2O2-mediated permeability: role of MAPK and occludin.Am J Physiol Cell Physiol,279(1):C21-C30.

[64]KhayatanD,RazaviSM,ArabZN,et al.,2022.Protective effects of curcumin against traumatic brain injury.Biomed Pharmacother,154:113621.

[65]KimC,FavazzaC,WangLV,2010.In vivo photoacoustic tomography of chemicals: high-resolution functional and molecular optical imaging at new depths.Chem Rev,110(5):2756-2782.

[66]KuSH,RyuJ,HongSK,et al.,2010.General functionalization route for cell adhesion on non-wetting surfaces.Biomaterials,31(9):2535-2541.

[67]KuzuharaT,SeiY,YamaguchiK,et al.,2006.DNA and RNA as new binding targets of green tea catechins.J Biol Chem,281(25):17446-17456.

[68]LeeH,DellatoreSM,MillerWM,et al.,2007.Mussel-inspired surface chemistry for multifunctional coatings.Science,318(5849):426-430.

[69]LeeH,KimWI,YounW,et al.,2018.Iron gall ink revisited: in situ oxidation of Fe(II)-tannin complex for fluidic-interface engineering.Adv Mater,30(49):1805091.

[70]LevineZA,RappMV,WeiW,et al.,2016.Surface force measurements and simulations of mussel-derived peptide adhesives on wet organic surfaces.Proc Natl Acad Sci USA,113(16):4332-4337.

[71]LiGL,YeCS,ZhuY,et al.,2022.Oxidative injury in ischemic stroke: a focus on NADPH oxidase 4.Oxid Med Cell Longev,2022:1148874.

[72]LiHM,YinD,LiW,et al.,2021.Polydopamine-based nanomaterials and their potentials in advanced drug delivery and therapy.Colloids Surf B Biointerfaces,199:111502.

[73]LiJC,DaiSQ,QinRX,et al.,2021.Ligand engineering of titanium-oxo nanoclusters for cerenkov radiation-reinforced photo/chemodynamic tumor therapy.ACS Appl Mater Interfaces,13(46):54727-54738.

[74]LiSC,WangJG,JacobsonP,et al.,2009.Correlation between bonding geometry and band gap states at organic-inorganic interfaces:catechol on rutile TiO2(110).J Am Chem Soc,131(3):980-984.

[75]LiTZ,LiJF,ChenZ,et al.,2022.Glioma diagnosis and therapy: current challenges and nanomaterial-based solutions.J Control Release,352:338-370.

[76]LiY,MiaoY,YangLN,et al.,2022.Recent advances in the development and antimicrobial applications of metal-phenolic networks.Adv Sci,9(27):2202684.

[77]LiYW,XieYJ,WangZ,et al.,2016.Structure and function of iron-loaded synthetic melanin.ACS Nano,10(11):10186-10194.

[78]LiangK,ChungJE,GaoSJ,et al.,2018.Highly augmented drug loading and stability of micellar nanocomplexes composed of doxorubicin and poly(ethylene glycol)‍-green tea catechin conjugate for cancer therapy.Adv Mater,30(14):1706963.

[79]LinKP,GanY,ZhuPD,et al.,2021.Hollow mesoporous polydopamine nanospheres: synthesis, biocompatibility and drug delivery.Nanotechnology,32(28):285602.

[80]LiuXS,CaoJM,LiH,et al.,2013.Mussel-inspired polydopamine: a biocompatible and ultrastable coating for nanoparticlesin vivo.ACS Nano,7(10):9384-9395.

[81]LiuYL,AiKL,LuLH,2014.Polydopamine and its derivative materials: synthesis and promising applications in energy, environmental, and biomedical fields.Chem Rev,114(9):5057-5115.

[82]LiuYL,AiKL,JiXY,et al.,2017.Comprehensive insights into the multi-antioxidative mechanisms of melanin nanoparticles and their application to protect brain from injury in ischemic stroke.J Am Chem Soc,139(2):856-862.

[83]LloydKCK,MeehanT,BeaudetA,et al.,2015.Precision medicine: look to the mice.Science,349(6246):390.

[84]LomasH,JohnstonAPR,SuchGK,et al.,2011.Polymersome-loaded capsules for controlled release of DNA.Small,7(14):2109-2119.

[85]LuRF,ZhangXQ,ChengXX,et al.,2020.Medical applications based on supramolecular self-assembled materials from tannic acid.Front Chem,8:583484.

[86]LvLJ,YangF,LiH,et al.,2020.Brain-targeted co-delivery of β‍-amyloid converting enzyme 1 shRNA and epigallocatechin-3-gallate by multifunctional nanocarriers for Alzheimer’s disease treatment.IUBMB Life,72(8):1819-1829.

[87]MaT,WuJH,MuJF,et al.,2022.Biomaterials reinforced MSCs transplantation for spinal cord injury repair.Asian J Pharm Sci,17(1):4-19.

[88]Magid-BernsteinJ,GirardR,PolsterS,et al.,2022.Cerebral hemorrhage: pathophysiology, treatment, and future directions.Circ Res,130(8):1204-1229.

[89]MarkusHS,2004.Cerebral perfusion and stroke.J Neurol Neurosurg Psychiatry,75(3):353-361.

[90]MarquesMS,CordeiroMF,MarinhoMAG,et al.,2020.Curcumin-loaded nanoemulsion improves haemorrhagic stroke recovery inwistar rats.Brain Res,1746:147007.

[91]MarslinG,SarmentoBFCC,FranklinG,et al.,2017.Curcumin encapsulated into methoxy poly(ethylene glycol) poly(ε-caprolactone) nanoparticles increases cellular uptake and neuroprotective effect in glioma cells.Planta Med,83(5):434-444.

[92]MedintzIL,StewartMH,TrammellSA,et al.,2010.Quantum-dot/dopamine bioconjugates function as redox coupled assemblies forin vitro and intracellular pH sensing.Nat Mater,9(8):676-684.

[93]MengJN,AgrahariV,YoumI,2017.Advances in targeted drug delivery approaches for the central nervous system tumors: the inspiration of nanobiotechnology.J Neuroimmune Pharmacol,12(1):84-98.

[94]MoYS,DuanLN,YangYN,et al.,2021.Nanoparticles improved resveratrol brain delivery and its therapeutic efficacy against intracerebral hemorrhage.Nanoscale,13(6):3827-3840.

[95]MontañoA,HanleyDF,HemphillJC III,2021.Hemorrhagic stroke.Handb Clin Neurol,176:229-248.

[96]MukherjeeS,BaidooJNE,SampatS,et al.,2018.Liposomal tricurin, a synergistic combination of curcumin, epicatechin gallate and resveratrol, repolarizes tumor-associated microglia/macrophages, and eliminates glioblastoma (GBM) and GBM stem cells.Molecules,23(1):201.

[97]NasrM,2016.Development of an optimized hyaluronic acid-based lipidic nanoemulsion co-encapsulating two polyphenols for nose to brain delivery.Drug Deliv,23(4):1444-1452.

[98]NguyenTT,Dung NguyenTT,VoTK,et al.,2021.Nanotechnology-based drug delivery for central nervous system disorders.Biomed Pharmacother,143:112117.

[99]NiuMM,HanY,LiQR,et al.,2018.Endogenous sulfur dioxide regulates hippocampal neuron apoptosis in developing epileptic rats and is associated with the PERK signaling pathway.Neurosci Lett,665:22-28.

[100]OhHI,HoffJE,ArmstrongGS,et al.,1980.Hydrophobic interaction in tannin-protein complexes.J Agric Food Chem,28(2):394-398.

[101]OuberaiM,DumyP,ChiericiS,et al.,2009.Synthesis and biological evaluation of clicked curcumin and clicked KLVFFA conjugates as inhibitors of β-amyloid fibril formation.Bioconjug Chem,20(11):2123-2132.

[102]OvbiageleB,2008.Potential role of curcumin in stroke prevention.Expert Rev Neurother,8(8):1175-1176.

[103]PetersO,BackT,LindauerU,et al.,1998.Increased formation of reactive oxygen species after permanent and reversible middle cerebral artery occlusion in the rat.J Cereb Blood Flow Metab,18(2):196-205.

[104]Piljac-ŽegaracJ,BelščakA,PiljacA,2009.Antioxidant capacity and polyphenolic content of blueberry (Vaccinium corymbosum L.)leaf infusions. J Med Food,12(3):608-614.

[105]PingY,GuoJL,EjimaH,et al.,2015.pH-responsive capsules engineered from metal-phenolic networks for anticancer drug delivery.Small,11(17):2032-2036.

[106]PrinzM,PrillerJ,2017.The role of peripheral immune cells in the CNS in steady state and disease.Nat Neurosci,20(2):136-144.

[107]QiaoB,LuoYL,ChengHB,et al.,2020.Artificial nanotargeted cells with stable photothermal performance for multimodal imaging-guided tumor-specific therapy.ACS Nano,14(10):12652-12667.

[108]QinJ,GuanYX,LiZJ,et al.,2022.Aptamer conjugated polydopamine-coated gold nanoparticles as a dual-action nanoplatform targeting β-amyloid peptide for Alzheimer’s disease therapy.J Mater Chem B,10(41):8525-8534.

[109]QiuJC,ShiYF,XiaYN,2021.Polydopamine nanobottles with photothermal capability for controlled release and related applications.Adv Mater,33(45):2104729.

[110]QiuXL,WangXL,HeYX,et al.,2021.Superstructured mesocrystals through multiple inherent molecular interactions for highly reversible sodium ion batteries.Sci Adv,7(37):eabh3482.

[111]QiuZY,YuZH,XuT,et al.,2022.Novel nano-drug delivery system for brain tumor treatment.Cells,11(23):3761.

[112]QuYJ,de RoseR,KimCJ,et al.,2023.Supramolecular polyphenol-DNA microparticles for in vivo adjuvant and antigen co-delivery and immune stimulation.Angew Chem Int Ed,62(12):e202214935.

[113]Quang TranH,BhaveM,YuAM,2020.Current advances of hollow capsules as controlled drug delivery systems.ChemistrySelect,5(19):5537-5551.

[114]QuideauS,DeffieuxD,Douat-CasassusC,et al.,2011.Plant polyphenols: chemical properties, biological activities, and synthesis.Angew Chem Int Ed,50(3):586-621.

[115]RajanS,KaasB,2022.Parkinson’s disease: risk factor modification and prevention.Semin Neurol,42(5):626-638.

[116]ReichardCA,StephensonAJ,KleinEA,2015.Applying precision medicine to the active surveillance of prostate cancer.Cancer,121(19):3403-3411.

[117]RenYZ,ZhaoX,LiangXF,et al.,2017.Injectable hydrogel based on quaternized chitosan, gelatin and dopamine as localized drug delivery system to treat Parkinson’s disease.Int J Biol Macromol,105(Pt 1):1079-1087.

[118]RongL,ZhangY,LiWS,et al.,2019.Iron chelated melanin-like nanoparticles for tumor-associated macrophage repolarization and cancer therapy.Biomaterials,225:119515.

[119]RossCA,PoirierMA,2004.Protein aggregation and neurodegenerative disease.Nat Med,10(7):S10-S17.

[120]Rugg-GunnF,MiserocchiA,McEvoyA,2020.Epilepsy surgery.Pract Neurol,20(1):4-14.

[121]SaP,SinghP,DilnawazF,et al.,2022.Application of therapeutic nanoplatforms as a potential candidate for the treatment of CNS disorders: challenges and possibilities.Curr Pharm Des,28(33):2742-2757.

[122]SaeediM,EslamifarM,KhezriK,et al.,2019.Applications of nanotechnology in drug delivery to the central nervous system.Biomed Pharmacother,111:666-675.

[123]SalomäkiM,MarttilaL,KiveläH,et al.,2018.Effects of pH and oxidants on the first steps of polydopamine formation: a thermodynamic approach.J Phys Chem B,122(24):6314-6327.

[124]SardoiwalaMN,SrivastavaAK,KaundalB,et al.,2020.Recuperative effect of metformin loaded polydopamine nanoformulation promoting EZH2 mediated proteasomal degradation of phospho-α-synuclein in Parkinson’s disease model.Nanomedicine,24:102088.

[125]SardoiwalaMN,MohanbhaiSJ,KarmakarS,et al.,2022.Hytrin loaded polydopamine-serotonin nanohybrid induces IDH2 mediated neuroprotective effect to alleviate Parkinson’s disease.Biomater Adv,133:112602.

[126]SchepiciG,BramantiP,MazzonE,2020.Efficacy of sulforaphane in neurodegenerative diseases.Int J Mol Sci,21(22):8637.

[127]SchulmanS,BeythRJ,KearonC,et al.,2008.Hemorrhagic complications of anticoagulant and thrombolytic treatment: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).Chest,133(6):257S-298S.

[128]ShakeelF,FazalMW,ZulfiqarA,et al.,2022.Melamine-derived N-rich C-entrapped au nanoparticles for sensitive and selective monitoring of dopamine in blood samples.RSC Adv,12(40):26390-26399.

[129]ShaoLH,LiYH,HuangFF,et al.,2020.Complementary autophagy inhibition and glucose metabolism with rattle-structured polydopamine@mesoporous silica nanoparticles for augmented low-temperature photothermal therapy and in vivo photoacoustic imaging.Theranostics,10(16):7273-7286.

[130]SharmaA,KumarA,LiCN,et al.,2021.A cannabidiol-loaded Mg-gallate metal-organic framework-based potential therapeutic for glioblastomas.J Mater Chem B,9(10):2505-2514.

[131]ShenWW,WangQW,ShenY,et al.,2018.Green tea catechin dramatically promotes RNAi mediated by low-molecular-weight polymers.ACS Cent Sci,4(10):1326-1333.

[132]ShiJJ,YangY,YinN,et al.,2022.Engineering CXCL12 biomimetic decoy-integrated versatile immunosuppressive nanoparticle for ischemic stroke therapy with management of overactivated brain immune microenvironment.Small Methods,6(1):2101158.

[133]ShinM,RyuJH,ParkJP,et al.,2015.DNA/tannic acid hybrid gel exhibiting biodegradability, extensibility, tissue adhesiveness, and hemostatic ability.Adv Funct Mater,25(8):1270-1278.

[134]ShinM,LeeHA,LeeM,et al.,2018.Targeting protein and peptide therapeutics to the heart via tannic acid modification.Nat Biomed Eng,2(5):304-317.

[135]ShutavaTG,BalkundiSS,LvovYM,2009.(-)-Epigallocatechin gallate/gelatin layer-by-layer assembled films and microcapsules.J Colloid Interface Sci,330(2):276-283.

[136]SileikaTS,BarrettDG,ZhangR,et al.,2013.Colorless multifunctional coatings inspired by polyphenols found in tea, chocolate, and wine.Angew Chem Int Ed,52(41):10766-10770.

[137]SrivastavaAK,RoyChoudhury S,KarmakarS,2020.Melatonin/polydopamine nanostructures for collective neuroprotection-based Parkinson’s disease therapy.Biomater Sci,8(5):1345-1363.

[138]SweeneyMD,ZhaoZ,MontagneA,et al.,2019.Blood‒brain barrier: from physiology to disease and back.Physiol Rev,99(1):21-78.

[139]TanLF,TangWT,LiuTL,et al.,2016.Biocompatible hollow polydopamine nanoparticles loaded ionic liquid enhanced tumor microwave thermal ablation in vivo.ACS Appl Mater Interfaces,8(18):11237-11245.

[140]TangW,FanWP,LauJ,et al.,2019.Emerging blood‒brain-barrier-crossing nanotechnology for brain cancer theranostics.Chem Soc Rev,48(11):2967-3014.

[141]TangXL,JingF,LinBL,et al.,2018.pH-responsive magnetic mesoporous silica-based nanoplatform for synergistic photodynamic therapy/chemotherapy.ACS Appl Mater Interfaces,10(17):15001-15011.

[142]Terelak-BorysB,SkoniecznaK,Grabska-LiberekI,2012.Ocular ischemic syndrome ‒ a systematic review.Med Sci Monit,18(8):RA138-RA144.

[143]TianY,YounisMR,TangYX,et al.,2021.Dye-loaded mesoporous polydopamine nanoparticles for multimodal tumor theranostics with enhanced immunogenic cell death.J Nanobiotechnology,19:365.

[144]TomaszewskiW,Sanchez-PerezL,GajewskiTF,et al.,2019.Brain tumor microenvironment and host state: implications for immunotherapy.Clin Cancer Res,25(14):4202-4210.

[145]ValvonaCJ,FillmoreHL,NunnPB,et al.,2016.The regulation and function of lactate dehydrogenase A: therapeutic potential in brain tumor.Brain Pathol,26(1):3-17.

[146]van HungP,2016.Phenolic compounds of cereals and their antioxidant capacity.Crit Rev Food Sci Nutr,56(1):25-35.

[147]VongLB,SatoY,ChonpathompikunlertP,et al.,2020.Self-assembled polydopamine nanoparticles improve treatment in Parkinson’s disease model mice and suppress dopamine-induced dyskinesia.Acta Biomater,109:220-228.

[148]WanJR,RenHL,WangJ,2019.Iron toxicity, lipid peroxidation and ferroptosis after intracerebral haemorrhage.Stroke Vasc Neurol,4(2):93-95.

[149]WangCP,SangHJ,WangYT,et al.,2018.Foe to friend: supramolecular nanomedicines consisting of natural polyphenols and bortezomib.Nano Lett,18(11):7045-7051.

[150]WangCY,HuangR,LiC,et al.,2019.Vepoloxamer enhances fibrinolysis of tPA (tissue-type plasminogen activator) on acute ischemic stroke.Stroke,50(12):3600-3608.

[151]WangW,ZhengJY,ZhouH,et al.,2022.Polydopamine-based nanocomposite as a biomimetic antioxidant with a variety of enzymatic activities for Parkinson’s disease.ACS Appl Mater Interfaces,14(29):32901-32913.

[152]WangWJ,TangQ,YuTR,et al.,2017.Surfactant-free preparation of Au@resveratrol hollow nanoparticles with photothermal performance and antioxidant activity.ACS Appl Mater Interfaces,9(4):3376-3387.

[153]WangXY,YanJJ,WangLZ,et al.,2020.Oral delivery of anti-TNF antibody shielded by natural polyphenol-mediated supramolecular assembly for inflammatory bowel disease therapy.Theranostics,10(23):10808-10822.

[154]WangXY,ZhangYM,LiT,et al.,2023.Bioorthogonal glycoengineering-mediated multifunctional liquid metal nanoprobes for highly efficient photoacoustic imaging-guided photothermal/chemotherapy of tumor.ACS Appl Bio Mater,6(8):3232-3240.

[155]WangZQ,WangLC,PrabhakarN,et al.,2019.CaP coated mesoporous polydopamine nanoparticles with responsive membrane permeation ability for combined photothermal and siRNA therapy.Acta Biomater,86:416-428.

[156]WarrenN,O'GormanC,LehnA,et al.,2017.Dopamine dysregulation syndrome in Parkinson’s disease: a systematic review of published cases.J Neurol Neurosurg Psychiatry,88(12):1060-1064.

[157]WeiYC,QuanL,ZhouC,et al.,2018.Factors relating to the biodistribution & clearance of nanoparticles & their effects onin vivo application.Nanomedicine,13(12):1495-1512.

[158]WilliamsET,ChenX,OteroPA,et al.,2022.Understanding the contributions of VPS35 and the retromer in neurodegenerative disease.Neurobiol Dis,170:105768.

[159]WuD,ZhouJJ,CreyerMN,et al.,2021.Phenolic-enabled nanotechnology: versatile particle engineering for biomedicine.Chem Soc Rev,50(7):4432-4483.

[160]WuD,FeiF,ZhangQ,et al.,2022.Nanoengineered on-demand drug delivery system improves efficacy of pharmacotherapy for epilepsy.Sci Adv,8(2):eabm3381.

[161]WuPK,ZhangHT,YinY,et al.,2022.Engineered EGCG-containing biomimetic nanoassemblies as effective delivery platform for enhanced cancer therapy.Adv Sci,9(15):2105894.

[162]XiangSY,YangP,GuoH,et al.,2017.Green tea makes polyphenol nanoparticles with radical-scavenging activities.Macromol Rapid Commun,38(23):1700446.

[163]XieJB,ShenZY,AnrakuY,et al.,2019.Nanomaterial-based blood-brain-barrier (BBB) crossing strategies.Biomaterials,224:119491.

[164]XuJ,ChenZQ,YuF,et al.,2020.IL-4/STAT6 signaling facilitates innate hematoma resolution and neurological recovery after hemorrhagic stroke in mice.Proc Natl Acad Sci USA,117(51):32679-32690.

[165]XuJH,MaCY,HuaML,et al.,2022.CNS and CNS diseases in relation to their immune system.Front Immunol,13:1063928.

[166]XuJP,ChenTY,TaiCH,et al.,2023.Bioactive self-healing hydrogel based on tannic acid modified gold nano-crosslinker as an injectable brain implant for treating Parkinson’s disease.Biomater Res,27(1):8.

[167]XuSB,ChangLN,ZhaoXJ,et al.,2022.Preparation of epigallocatechin gallate decorated Au-Ag nano-heterostructures as NIR-sensitive nano-enzymes for the treatment of osteoarthritis through mitochondrial repair and cartilage protection.Acta Biomater,144:168-182.

[168]XuSH,NieYY,JiangLP,et al.,2018.Polydopamine nanosphere/gold nanocluster (Au NC)‍-based nanoplatform for dual color simultaneous detection of multiple tumor-related micrornas with DNase-I-assisted target recycling amplification.Anal Chem,90(6):4039-4045.

[169]XuanMJ,ZhaoJ,ShaoJX,et al.,2017.Recent progresses in layer-by-layer assembled biogenic capsules and their applications.J Colloid Interface Sci,487:107-117.

[170]XueJH,ZhengWC,WangL,et al.,2016.Scalable fabrication of polydopamine nanotubes based on curcumin crystals.ACS Biomater Sci Eng,2(4):489-493.

[171]XueS,ZhouXJ,SangWL,et al.,2021.Cartilage-targeting peptide-modified dual-drug delivery nanoplatform with NIR laser response for osteoarthritis therapy.Bioact Mater,6(8):2372-2389.

[172]YangGB,PhuaSZF,BindraAK,et al.,2019.Degradability and clearance of inorganic nanoparticles for biomedical applications.Adv Mater,31(10):1805730.

[173]YangXJ,LiuX,LiuZ,et al.,2012.Near-infrared light-triggered, targeted drug delivery to cancer cells by aptamer gated nanovehicles.Adv Mater,24(21):2890-2895.

[174]YildirimA,BayindirM,2014.Turn-on fluorescent dopamine sensing based onin situ formation of visible light emitting polydopamine nanoparticles.Anal Chem,86(11):5508-5512.

[175]YuB,WangDA,YeQ,et al.,2009.Robust polydopamine nano/microcapsules and their loading and release behavior.Chem Commun,44:6789-6791.

[176]YuWY,YinN,YangY,et al.,2022.Rescuing ischemic stroke by biomimetic nanovesicles through accelerated thrombolysis and sequential ischemia-reperfusion protection.Acta Biomater,140:625-640.

[177]YuX,FanHL,WangL,et al.,2014.Formation of polydopamine nanofibers with the aid of folic acid.Angew Chem Int Ed,53(46):12600-12604.

[178]ZhangHH,SunY,HuangR,et al.,2018.pH-sensitive prodrug conjugated polydopamine for NIR-triggered synergistic chemo-photothermal therapy.Eur J Pharm Biopharm,128:260-271.

[179]ZhangHY,van OsWL,TianXB,et al.,2021.Development of curcumin-loaded zein nanoparticles for transport across the blood‒brain barrier and inhibition of glioblastoma cell growth.Biomater Sci,9(21):7092-7103.

[180]ZhangLR,YangP,GuoRR,et al.,2019.Multifunctional meso

[181]porous polydopamine with hydrophobic paclitaxel for photoacoustic imaging-guided chemo-photothermal synergistic therapy.Int J Nanomedicine,14:8647-8663.

[182]ZhangMJ,JiangYX,QiKZ,et al.,2021.Precise engineering of acorn-like Janus nanoparticles for cancer theranostics.Acta Biomater,130:423-434.

[183]ZhangP,ZhangY,DingXY,et al.,2020.A multistage cooperative nanoplatform enables intracellular co-delivery of proteins and chemotherapeutics for cancer therapy.Adv Mater,32(46):2000013.

[184]ZhangQY,LiLB,2018.Photodynamic combinational therapy in cancer treatment.J BUON,23(3):561-567.

[185]ZhangSS,AsgharS,ZhuCQ,et al.,2021.Multifunctional nanorods based on self-assembly of biomimetic apolipoprotein E peptide for the treatment of Alzheimer’s disease.J Control Release,335:637-649.

[186]ZhangWJ,ChristoffersonAJ,BesfordQA,et al.,2019.Metal-dependent inhibition of amyloid fibril formation: synergistic effects of cobalt-tannic acid networks.Nanoscale,11(4):1921-1928.

[187]ZhangYL,XiKY,FuX,et al.,2021.Versatile metal-phenolic network nanoparticles for multitargeted combination therapy and magnetic resonance tracing in glioblastoma.Biomaterials,278:121163.

[188]ZhaoNX,YangX,CalvelliHR,et al.,2020.Antioxidant nanoparticles for concerted inhibition of α-synuclein fibrillization, and attenuation of microglial intracellular aggregation and activation.Front Bioeng Biotechnol,8:112.

[189]ZhaoX,YeY,GeSY,et al.,2020.Cellular and molecular targeted drug delivery in central nervous system cancers: advances in targeting strategies.Curr Top Med Chem,20(30):2762-2776.

[190]ZhaoYM,LiDL,ZhuZF,et al.,2020.Improved neuroprotective effects of gallic acid-loaded chitosan nanoparticles against ischemic stroke.Rejuvenation Res,23(4):284-292.

[191]ZhouJJ,JiangYY,HouS,et al.,2018.Compact plasmonic blackbody for cancer theranosis in the near-infrared II window.ACS Nano,12(3):2643-2651.

[192]ZhouJJ,LinZX,JuY,et al.,2020.Polyphenol-mediated assembly for particle engineering.ACC Chem Res,53(7):1269-1278.

[193]ZhouQ,LiuXX,TianY,et al.,2017.Mussel-inspired polydopamine coating on tobacco mosaic virus: one-dimensional hybrid nanofibers for gold nanoparticle growth.Langmuir,33(38):9866-9872.

[194]ZhouZD,XieSP,SawWT,et al.,2019.The therapeutic implications of tea polyphenols against dopamine (DA) neuron degeneration in Parkinson’s disease (PD).Cells,8(8):911.

[195]ZhuF,ZhangJH,ZhongJ,et al.,2023.Natural polyphenol-based nanoparticles for the treatment of iron-overload disease.J Control Release,356:84-92.

[196]ZhuHT,CaoXF,CaiXJ,et al.,2020.Pifithrin-μ incorporated in gold nanoparticle amplifies pro-apoptotic unfolded protein response cascades to potentiate synergistic glioblastoma therapy.Biomaterials,232:119677.

[197]ZhuTT,WangH,GuHW,et al.,2023.Melanin-like polydopamine nanoparticles mediating anti-inflammatory and rescuing synaptic loss for inflammatory depression therapy.J Nanobiotechnology,21:52.

Open peer comments: Debate/Discuss/Question/Opinion

<1>

Please provide your name, email address and a comment





Journal of Zhejiang University-SCIENCE, 38 Zheda Road, Hangzhou 310027, China
Tel: +86-571-87952783; E-mail: cjzhang@zju.edu.cn
Copyright © 2000 - 2024 Journal of Zhejiang University-SCIENCE